Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Makobetsa Khati

Makobetsa Khati

CSIR Biosciences, South Africa

Title: Synthetic RNA molecule mitigates HIV-induced apoptosis of cardiomyocytes and also prevents HIV infection

Biography

Biography: Makobetsa Khati

Abstract

Chronic HIV infection causes a broad range of clinical complications, some of which remain poorly understood. One such complication is HIV-associated cardiomyopathy (HIVCM). In this study, we evaluated a novel approach to mitigate HIVCM using synthetic RNA molecules called aptamers. Specifically, we used a shortened synthetic derivative of anti-gp120 aptamer called UCLA1. The aptamer protected cardiomyocytes from HIV induced apoptosis. Furthermore, the aptamer also prevented infection of human macrophages and CD4+ T cells by a broad range of clinical isolates of HIV-1 from different subtypes. Taken together, these data argue in favor of further development of this RNA synthetic molecule to prevent HIV infection in uninfected individuals, and also to mitigate AIDS pathogenesis such as HIVCM in already infected individuals.